Patheon has entered a definitive agreement to acquire Agere Pharmaceuticals, a CDMO headquartered in Bend, OR, that specializes in bioavailability. The transaction is subject to customary closing conditions.   Agere helps customers improve the absorption rate and delivery of medications through its solubilization expertise and technologies. The Bend facility will serve as a solubility center of excellence and will fall under Patheon’s pharmaceutical development services (PDS) operations. C...